Stemina Biomarker Discovery, Inc. Email Format
Biotechnology ResearchWisconsin, United States2-10 Employees
Stemina Biomarker Discovery, Inc. is a biotechnology research company that focuses on identifying and developing molecular biomarkers to improve drug safety and human health. Its work centers on analyzing small molecules secreted by human embryonic stem cells and differentiated cells, using this metabolic information to assess how drugs, injury, or disease affect cellular systems. The firm aims to support the development and commercialization of biomarker-based tests that can inform safety assessments and health outcomes. Headquartered in Madison, Wisconsin, Stemina operates in a niche within the biotechnology and metabolomics space, leveraging stem cell–based assays to generate clinically relevant insights. The company opened its facilities for stem cell culture and mass spectrometry in the UW Research Park in Madison in 2007, reflecting its long-standing focus on building advanced cellular models for biomarker discovery. In 2017, the organization announced the appointment of a new board member with experience in commercialization strategy, as it prepared to bring an autism diagnostic test panel to market.